Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Adicionar filtros








Intervalo de ano
2.
Yonsei Medical Journal ; : 362-369, 1991.
Artigo em Inglês | WPRIM | ID: wpr-115651

RESUMO

Within the past few years, an increasing number of reports of Hodgkin's disease following the diagnosis of, and frequently coexisting with, mycosis fungoides have appeared. Previously, Hodgkin's disease found in the lymph nodes of the patient diagnosed as mycosis fungoides was considered as a transformed form of the mycosis fungoides. But, now it has been proven that Hodgkin's disease and mycosis fungoides are histologically and immunohistochemically distinct disease entities. We report a well-documented case of a man who developed Hodgkin's disease and mycosis fungoides simultaneously as a composite lymphoma. Our case emphasizes the importance of considering the diagnosis of another lymphoma in patients with mycosis fungoides who have lymphadenopathy. The cutaneous mycosis fungoides and the Hodgkin's disease should be treated as an independent disease.


Assuntos
Adulto , Humanos , Masculino , Doença de Hodgkin/patologia , Micose Fungoide/patologia , Neoplasias Primárias Múltiplas/patologia , Neoplasias Cutâneas/patologia
4.
5.
Journal of the Korean Cancer Association ; : 606-618, 1991.
Artigo em Coreano | WPRIM | ID: wpr-55143

RESUMO

No abstract available.


Assuntos
Trato Gastrointestinal , Leiomiossarcoma
6.
Yonsei Medical Journal ; : 126-130, 1991.
Artigo em Inglês | WPRIM | ID: wpr-33128

RESUMO

Twelve male patients with operable breast cancer were evaluated for the expression of prognostic factors by immunohistochemical staining assay. Seven patients were stage I and II, and five patients were stage III. Axillary lymph node positivity was 42%. Nine patients were nuclear grade I, three were nuclear grade II, and none were nuclear grade III. The expression rate of EGFR (epidermal growth factor receptor), ER (estrogen receptor) were 8.3%, 70.0% respectively. This limited data suggest better tumor behavior in male than in female breast cancer. Adjuvant treatment should be considered in male breast cancer just as in females, based on axillary lymph node and ER states.


Assuntos
Humanos , Masculino , Neoplasias da Mama/química , Carcinoma/química , Imuno-Histoquímica , Metástase Linfática , Estadiamento de Neoplasias , Prognóstico , Receptores ErbB/análise , Receptores de Estrogênio/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA